Filing Details

Accession Number:
0001640334-20-002026
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-11 14:52:32
Reporting Period:
2020-08-07
Accepted Time:
2020-08-11 14:52:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516551 Emerald Bioscience Inc. EMBI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261140 L James Heppell 5910 Pacific Center Blvd
Suite 320
San Diego CA 92121
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-07 500,000 $50,000.00 500,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Option Grant (Right to Buy) Acquisiton 2020-08-07 1,000,000 $0.00 1,000,000 $0.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,200,000 2030-08-07 No 4 A Direct
Footnotes
  1. Private purchase transaction from Emerald Health Sciences at $0.10 per share.
  2. Each of the Options shall be exercisable for a price of $0.045 per Option Share for ten years from August 7, 2020 (the "Grant Date") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over two years.